Publish dateTuesday 7 June 2022 - 15:33
Story Code : 253945
Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.
Pfizer Inc (PFE.N) said it would spend $120 million to expand manufacturing of its COVID-19 antiviral treatment at its Michigan plant.
Afghan Voice Agency (AVA)_Use of the pill, Paxlovid, authorized to treat newly infected, at-risk people to prevent severe illness, has soared recently as infections rise.

Biden administration officials have pushed for the wider use of Paxlovid, which the government distributes for free.
 
https://avapress.net/vdchkxnim23nmwd.01t2.html
Post a comment
Your Name
Your Email Address